Comparison of the number and content of pathology laboratory samples before and after the COVID-19 pandemic.

IF 0.7 4区医学 Q4 PATHOLOGY Polish Journal of Pathology Pub Date : 2023-01-01 DOI:10.5114/pjp.2023.128964

Leymune Parlak, Emine Zeynep Tarini

{"title":"Comparison of the number and content of pathology laboratory samples before and after the COVID-19 pandemic.","authors":"Leymune Parlak, Emine Zeynep Tarini","doi":"10.5114/pjp.2023.128964","DOIUrl":null,"url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) has caused respiratory system diseases and affected people's access to healthcare services for diseases other than COVID-19. After the COVID-19 pandemic, changes occurred in the number and content of pathology laboratory samples, related to measures such as reducing the number of outpatient clinics in hospitals, postponing elective surgery, and restricting cancer screening. All samples sent to the pathology laboratory between 2019 and 2020 were included in our study. Biopsy, cytology, histochemical, and immunohistochemical staining and biopsies for malignant cases were evaluated. Changes in sample number and content caused by the pandemic were examined. The number of biopsies was 24 312 in 2019 and 13 208 in 2020. On comparison, a decrease was observed in all parameters. The largest (78.5%) and smallest (11.02%) decreases were observed in examinations of the incoming preparations for consultation (214-46) and Trucut needle biopsies (726-646), respectively. Cases such as appendectomies that require urgent intervention and malignancies that require further examination and diagnosis are the least affected. However, whether the decrease in cancer screening will affect the early diagnosis and treatment of malignancies and create a public health problem in the future remains to be established.</p>","PeriodicalId":49692,"journal":{"name":"Polish Journal of Pathology","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polish Journal of Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/pjp.2023.128964","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Coronavirus disease 2019 (COVID-19) has caused respiratory system diseases and affected people's access to healthcare services for diseases other than COVID-19. After the COVID-19 pandemic, changes occurred in the number and content of pathology laboratory samples, related to measures such as reducing the number of outpatient clinics in hospitals, postponing elective surgery, and restricting cancer screening. All samples sent to the pathology laboratory between 2019 and 2020 were included in our study. Biopsy, cytology, histochemical, and immunohistochemical staining and biopsies for malignant cases were evaluated. Changes in sample number and content caused by the pandemic were examined. The number of biopsies was 24 312 in 2019 and 13 208 in 2020. On comparison, a decrease was observed in all parameters. The largest (78.5%) and smallest (11.02%) decreases were observed in examinations of the incoming preparations for consultation (214-46) and Trucut needle biopsies (726-646), respectively. Cases such as appendectomies that require urgent intervention and malignancies that require further examination and diagnosis are the least affected. However, whether the decrease in cancer screening will affect the early diagnosis and treatment of malignancies and create a public health problem in the future remains to be established.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新冠肺炎大流行前后病理学实验室样本数量和含量的比较。

2019冠状病毒病（新冠肺炎）已导致呼吸系统疾病，并影响人们获得新冠肺炎以外疾病的医疗服务。新冠肺炎大流行后，病理学实验室样本的数量和内容发生了变化，这与减少医院门诊数量、推迟择期手术和限制癌症筛查等措施有关。2019年至2020年间送往病理学实验室的所有样本都包含在我们的研究中。对恶性病例的活检、细胞学、组织化学、免疫组织化学染色和活检进行了评估。对疫情造成的样本数量和内容的变化进行了检查。活检次数在2019年为24312次，在2020年为13208次。相比之下，观察到所有参数都有所下降。在咨询准备（214-46）和Trucut针活检（726-646）的检查中，分别观察到最大（78.5%）和最小（11.02%）的下降。需要紧急干预的阑尾切除术和需要进一步检查和诊断的恶性肿瘤等病例受影响最小。然而，癌症筛查的减少是否会影响恶性肿瘤的早期诊断和治疗，并在未来造成公共卫生问题，还有待确定。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Polish Journal of Pathology PATHOLOGY-

CiteScore

1.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Polish Journal of Pathology is an official magazine of the Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology. For the last 18 years of its presence on the market it has published more than 360 original papers and scientific reports, often quoted in reviewed foreign magazines. A new extended Scientific Board of the quarterly magazine comprises people with recognised achievements in pathomorphology and biology, including molecular biology and cytogenetics, as well as clinical oncology. Polish scientists who are working abroad and are international authorities have also been invited. Apart from presenting scientific reports, the magazine will also play a didactic and training role.